Cellulite Treatment in Vienna Austria
Cellulite Treatment
Cellulite is a skin condition commonly situated in the hips, thighs and buttocks. It has a cottage cheese appearance and multiple dimples on the skin. It is not related to being overweight but is genetic.
Cellulite treatment is not a surgical procedure. Treatment does not break the skin. It is a safe non-surgical approach to body contouring.
Best candidates are men and women who are in good health, have good skin tone and have realistic expectations. The results will produce an improvement in skin tone, the appearance of stretchmarks, and loose skin may be improved.
It is recommended to add diet and exercise to daily routine while undergoing cellulite treatments.
The cellulite treatment called Mesotherapy is considered very effective. The cellulite area develops increased blood flow and lymphatic flow, decreased fibrosis of the connective tissue and reduction of fat deposits. The result is smooth skin and cellulite reduction. This type of cellulite treatment uses a mixture of substances including vitamins, herbs and other homeopathic medications. This treatment is custom-tailored for each individual. Very short and thin needles re used to inject the formulations.
When treating cellulite, one formulation of medications may be used to dissolve fat, and another to destroy fibrous bands that bind the skin. This treatment is virtually painless. One can return to normal activities immediately.
The risks involved in this treatment are the possibility of allergic reaction to the mesotherapy solution. Since a needle is used, there is a possibility of infection at the site of injections. Mild or minor bruising at injection site is also a possibility. There may also be some itching after the treatment.
This procedure is performed in a medical setting. The patient does not need anesthesia. No post-operative recovery time. For those with sensitive skin, an anesthetic cream can be applied 1/2 hour before the treatment.
Another cellulite treatment is Lipodissolve. This is also a non-surgical procedure. This cellulite treatment involves the injection of phosphatidylcholine (PPC) into small fat deposits to dissolve fat. PPC is a natural enzyme. This compound is injected into the fat through multiple microinjections. The treatment is to dissolve fat which is removed through normal waste removal. It is virtually painless. No heavy bandages and one can resume work with no down time.
The procedure takes 30-60 minutes depending on areas treated. The patient can return to normal activities after the procedure.
The risks involved are the same as the above treatment. Plus the patient might feel light-headedness or slight nausea. This should pass quickly. The area treated will be swollen and tender for a few days and up to a few weeks.
SmartLipo, also known as laser liposuction is the latest fat removal treatment. This procedure involves the use of a laser that dissolves the fat and tightens the surrounding skin. This treatment is done in an office and does not require general anesthetic. The doctor will mark the targeted areas and local anesthetic is given. A small tube containing a laser is inserted into the skin. The laser's energy causes the fat cells to rupture and drain away. This is removed by the body's waste system. With this cellulite treatment, there is less bleeding and swelling. This causes the skin to tighten and shrink gradually in about 6-8 weeks.
The risks involved in this procedure are mild swelling, bruising or tenderness at site of insertion. There is rarely infection and a possibility of haematoma (collection of blood underneath the skin) following treatment. Asymmetrical results and minor scarring can be long term risks.
Best results are seen after 2 months. Downtime is minimal. The patient can return to work within 24 hours.
More Vienna info...
Vienna By car
Most Austrian highways ("Autobahn") terminate/originate in Vienna.
Unlike Germany, there is a strictly enforced speed limit of 130 km/h on highways. Within towns it is 50 km/h and on major roads, it is 100 km/h.
Also a Highway Toll Sticker (Vignette) is a must! Not having one can be really expensive. Usually they can be purchased at petrol (gas) stations.
Drivers in Austria are also required by law to carry certain safety equipment. This includes a reflective vest, first aid kit and traffic warning triangle[3]
It is required to keep your headlights on at all times while driving in Austria.
-
Vienna By plane
The Vienna International Airport (IATA: VIE) (ICAO: LOWW) is actually located in the suburb of "Schwechat". The airport "Wien-Schwechat" is the home base of the Flagcarrier Austrian and the budget airline Fly Niki. Most European airlines and a significant number of international airlines have direct connections to Vienna.
-
Plastic Surgery News...
- Scientific studies on the use of stem cells for cardiac repair, were examined this morning during the opening session of the Winter Research Meeting of the Heart Failure Association of the European Society of Cardiology. Findings in experiments conducted with rodent engineered heart tissue (EHT) in Germany, indicate the great potential of pluripotent stem cells for use in cardiac repair.
- Starting nicotine replacement therapy (NRT) as a transdermal patch before the target quit date doubles success rates according to a meta-analysis, although only four studies of varied design were eligible for analysis.
The authors of the analysis note that starting NRT before the quit date might improve smoking cessation rates by acclimatising users and separating nicotine intake from smoking. This approach has been most studied using transdermal patches, however trials have varied in size and duration. The aim of this analysis was to determine from the trial data whether a clear benefit had been shown. The authors searched for randomised controlled trials in which the effects of pre-quit treatment were compared directly with treatment starting on the target quit day. Eligible studies recruited smokers who were interested in quitting (rather than reduction), where all participants received NRT from the target quit date, where participants were randomised to receive pre-quit NRT or control (placebo or no NRT), and where cessation was verified 4 to 6 weeks later by biochemical analysis. Primary end-point for the analysis was continuous abstinence for at least 28 days assessed at 6 weeks following quit day, or the nearest reported outcome where this was not available; outcomes at six months were examined as secondary endpoints.
Four trials (n=755) were available and eligible for analysis, all involving nicotine patches: two trials involving nicotine gum were also located, however one was ineligible as a different pre-quit dose was used, and the second had not yet completed. The trials had different designs and durations, and two (n=176) also included treatment with mecamylamine (a nicotinic antagonist). Three studies originated from the same research team.
Analysis found that pre-quit treatment approximately doubled the quit rate at six weeks compared to starting NRT on the quit day (odds ratio 1.91; 95% CI, 1.31 to 2.93). A similar pattern was seen with results at six months (OR 2.17; 95% CI, 1.46 to 3.22). Co-administration of mecamylamine seemed to make no significant difference to the results. There was no evidence that one study was significantly influencing the pooled result - exclusion of each from analysis made little difference to the overall result.
Based on their analysis, the authors conclude that starting NRT patch therapy before the target quit date roughly doubles the chance of success, both in the short-term and up to six months. Although the studies differed widely in their design, the authors consider that the analysis suggests a consistent effect. They note that where the information was collected, there was spontaneous pre-quit reduction in smoking by subjects in the pre-quit group although none were instructed to do this. They discuss possible mechanisms for the effect including pharmacodynamic effects, effects on learned associations involved in smoking, and on extinction of smoking reinforcement.
[Editor's comment: an interesting analysis that appears to have been carefully done, but some cautions remain: the number of participants was relatively small, and it is a slight concern that most of the data came from one research team. This technique would not be covered by current NICE guidance on smoking cessation, and it is uncertain whether it would fit with the current product licences for NRT patches.]